首页> 美国卫生研究院文献>Infection and Immunity >Note: Intranasal Immunization of Mice with Influenza Vaccine in Combination with the Adjuvant LT-R72 Induces Potent Mucosal and Serum Immunity Which Is Stronger than That with Traditional Intramuscular Immunization
【2h】

Note: Intranasal Immunization of Mice with Influenza Vaccine in Combination with the Adjuvant LT-R72 Induces Potent Mucosal and Serum Immunity Which Is Stronger than That with Traditional Intramuscular Immunization

机译:注意:流感疫苗对小鼠的鼻内免疫结合佐剂LT-R72诱导的强力粘膜和血清免疫力强于传统的肌内免疫

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Immunization of mice by the intranasal route with influenza virus hemagglutinin in combination with the mutant Escherichia coli heat-labile enterotoxin R72 (LT-R72) induced significantly enhanced serum and mucosal antibodies, surpassing, in most cases, responses achieved by traditional intramuscular immunization using inactivated split influenza vaccine. Furthermore, intranasal immunization with LT-R72 induced a potent serum immunoglobulin G2a response, indicating that this adjuvant has Th1 character.
机译:通过鼻内途径用流感病毒血凝素与突变型大肠杆菌不耐热肠毒素R72(LT-R72)结合对小鼠进行免疫,可显着增强血清和粘膜抗体,在大多数情况下,其效果超过了使用灭活的传统肌内免疫所获得的反应分割流感疫苗。此外,用LT-R72进行鼻内免疫可诱导有效的血清免疫球蛋白G2a反应,表明该佐剂具有Th1特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号